Use access key #2 to skip to page content.
$36.50 -0.05 (-0.14%)
10/10/2008 4:02 PM

AstraZeneca plc (ADR) (AZN)

CAPS Rating:
****

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

View All Commentary (AZN)

Recs

0

Avatar pilarcity (90.64) Submitted: 1/22/08 5:09 PM : Outperform Start Price: $40.47 AZN Score: 20.55

Excellent combination of biotech and pharma portfolios.

Report this Post Replies: 0 | Reply

Featured Broker Partners